TEST BANK For Applied Pharmacology for theDen
v v v v v v v
tal Hygienist 9th Edition
v v v
by Elena Bablenis Haveles, Chapters 1 - 26 A+
v v v v v v v v
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and PrescriptionWriting
v v v v v v v v v v
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
v v v v v v v v
MULTIPLEvCHOICE
1. Knowledgevofvpharmacologyvaidsvthevdentalvprofessionalvin
a. obtainingvavpatient’svhealthvhistory.
b. administeringvdrugsvinvthevoffice.
c. handlingvemergencyvsituations.
d. selectionvofvavnonprescriptionvmedication.
e. Allvofvthevabove.
ANSWER:vE
Allvofvthevchoicesvarevtrue.vBecausevmanyvofvourvpatientsvarevbeingvtreatedvwithvdrugs,vknowledgevofvph
armacologyvhelpsvinvunderstandingvandvinterpretingvpatients’vresponsesvtovhealthvhistoryvquestions.vKno
wledgevofvthevtherapeuticvandvadverseveffectsvofvmedicationsvobviouslyvhelpsvinvtheirvpropervadministra
tionvinvthevoffice.vEmergencyvsituationsvmayvbevcausedvbyvdrugsvorvtreatedvbyvdrugs;vthus,vknowledgevof
vpharmacologyvisvofvgreatvhelp,vespeciallyvbecausevavrapidvresponsevisvsometimesvrequired.vAvclearvund
erstandingvofvthevconceptsvofvdrugvaction,vdrugvhandlingvbyvthevbody,vandvdrugvinteractionsvwillvallowvt
hevdentalvpractitionervtovmakevpropervjudgmentsvandvgraspvthevconceptsvrelevantvtovnewvdrugvtherapiesv
onvthevmarket.
DIF: Application
REF:v RolevofvthevDentalvHygienistv(Medication/HealthvHistory),vRolevofvthevDentalvHygienistv(MedicationvA
dministration),vRolevofvthevDentalvHygienistv(EmergencyvSituations),vRolevofvthevDentalvHygienistv(Nonpre
scriptionvMedication)v|vpp.v2-3 OBJ: 1
TOP:v NBDHE,v6.0.vPharmacology
2. Whichvofvthevfollowingvstatementsvisvtruevregardingvplanningvappointments?
a. Whethervorvnotvpatientsvarevtakingvmedicationvforvsystemicvdiseasesvisvofvlittle
consequencevinvthevdentalvoffice.
b. Asthmaticvpatientsvshouldvhavevdentalvappointmentsvinvthevmorning.
c. Diabeticvpatientsvusuallyvhavevfewervproblemsvwithvavmorningvappointment
comparedvwithvafternoonvappointments.
d. BothvBvandvCvarevtrue.
ANSWER:vD
Asthmaticvpatientsvwhovexperiencevdentalvanxietyvshouldvschedulevtheirvappointmentsvwhenvtheyvarevnot
vrushedvorvundervpressurevearlyvinvthevmorning.vDiabeticvpatientsvusuallyvhavevrelativelyvfewervproblem
svwithvavmorningvappointment.vPatientsvtakingvmedicationvforvsystemicvdiseasesvmayvrequirevspecialvhan
dlingvinvthevdentalvoffice.
, DIF: Comprehension
REF:v RolevofvthevDentalvHygienistv(AppointmentvScheduling)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
3. Nutritionalvorvherbalvsupplements
a. carryvthevU.S.vFoodvandvDrugvAdministrationv(FDA)vapprovalvforvdiseasevstates.
b. arevnotvdrugs.
c. canvcausevadverseveffects.
d. willvnotvinteractvwithvothervdrugsvthevpatientvmayvbevtaking.
ANSWER:vC
Nutritionalvorvherbalvsupplementsvarevquitevcapablevofvcausingvadverseveffects.vThevmajorityvofvn
utritionalvorvherbalvsupplementsvdovnotvcarryvFDAvapprovalvforvtreatingvdiseasevstates.vThesevsu
pplementsvarevdrugsvandvcanvcausevadverseveffectsvandvinteractvwithvdifferentvdrugs.
DIF:v Comprehension
REF:vRolevofvthevDentalvHygienistv(NutritionalvorvHerbalvSupplements)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
4. Whichvtypevofvdrugvnamevusuallyvbeginsvwithvavlowercasevletter?
a. Brandvname
b. Codevname
c. Genericvname
d. Tradevname
ANSWER:vC
Beforevanyvdrugvisvmarketed,vitvisvgivenvavgenericvnamevthatvbecomesvthev“official”vnamevofvthevdrug.vEa
chvdrugvisvassignedvonlyvonevgenericvnamevselectedvbyvthevU.S.vAdoptedvNamevCouncil,vandvthevnamevi
svnotvcapitalized.vThevbrandvnamevisvequivalentvtovthevtradevnamevandvisvcapitalized.vAlthoughvthevbrandv
namevisvtechnicallyvthevnamevofvthevcompanyvmarketingvthevproduct,vthisvtermvisvoftenvusedvinterchangea
blyvwithvthevtradevname.vThevcodevnamevisvthevinitialvtermvusedvwithinvavpharmaceuticalvcompanyvtovrefe
rvtovavdrugvwhilevitvisvundergoingvinvestigationvandvisvoftenvavcombinationvofvcapitalvlettersvandvnumber
s,vthevlettersvrepresentingvanvabbreviationvofvthevcompanyvname.
DIF: Comprehension
REF:vDrugvNamesv|vp.v4vOBJ:v 3
TOP:v NBDHE,v6.0.vPharmacology
5. Avdrug’svgenericvnamevisvselectedvbyvthe
a. pharmaceuticalvcompanyvmanufacturingvit.
b. FoodvandvDrugvAdministrationv(FDA).
c. U.S.vAdoptedvNamevCouncil.
d. FederalvPatentvOffice.
, ANSWER:vC
Eachvdrugvisvassignedvonlyvonevgenericvnamev(e.g.,vibuprofen).vItvisvselectedvbyvthevU.S.vAdoptedvName
vCouncil.vThevgenericvnamevisvnotvselectedvbyvthevFDAvorvthevFederal vPatentvOffice.vThevpharmaceutic
alvcompanyvmanufacturingvthevdrugvclearlyvhasvanvinfluencevonvthevgenericvnamevgivenvitsvdrug,vbutvthevf
inalvdecisionvisvnotvthevcompany’s.
DIF: Recall REF:v DrugvNamesv|vp.v4
OBJ:v 3vTOP:v NBDHE,v6.0.vPharmacology
6. Whichvofvthevfollowingvisvtruevconcerningvgenericvandvtradevnamesvofvdrugs?
a. Avdrugvmayvonlyvhavevonevgenericvnamevandvonevtradevname.
b. Avdrugvmayvonlyvhavevonevgenericvname,vbutvitvmayvhavevseveralvtradevnames.
c. Avdrugvmayvhavevseveralvgenericvnames,vbutvitvmayvonlyvhavevonevtradevname.
d. Avdrugvmayvhavevseveralvgenericvnamesvandvseveralvtradevnames.
ANSWER:vB
Eachvdrugvhasvonlyvonevgenericvnamevbutvmayvhavevseveralvtradevnames.vForveachvdrug,vtherevisvonlyvon
evgenericvname.vItvisvnotvcapitalized,vandvitvbecomesvthev“official”vnamevofvthevdrug.vThevpharmaceutical
vcompanyvdiscoveringvthevdrugvgivesvthevdrugvavtradevname.vThevtradevnamevisvprotectedvbyvthevFederalv
PatentvLawvforv20vyearsvfromvthevearliestvclaimedvfilingvdate,vplusvpatentvtermvextensions.vAlthoughvthevb
randvnamevisvtechnicallyvthevnamevofvthevcompanyvmarketingvthevproduct,vitvisvoftenvusedvinterchangeabl
yvwithvthevtradevname.
DIF: Comprehension
REF:vDrugvNamesv|vp.v4vOBJ:v 3
TOP:v NBDHE,v6.0.vPharmacology
7. Twovdrugsvthatvarevfoundvtovbevchemicallyvequivalent,vbutvnotvbiologicallyvequivalentvorvt
herapeuticallyvequivalentvarevsaidvtovdiffervin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticvindex.
ANSWER:vC
Avpreparationvcanvbevchemicallyvequivalentvyetvnotvbiologicallyvorvtherapeuticallyvequivalent.vThesevpr
oductsvarevsaidvtovdiffervinvtheirvbioavailability.vThevpotencyvofvavdrugvisvavfunctionvofvthevamountvofvdrug
vrequiredvtovproducevanveffect. vThevefficacyvisvthevmaximumvintensityvofveffectvorvresponsevthatvcanvbev
producedvbyvavdrug.vThevtherapeuticvindexvisvthevratiovofvthevlethalvdosevforv50%vofvthevexperimentalvan
imalsvdividedvbyvtheveffectivevdosevforv50%vofvthevexperimentalvanimals.vIfvthevvaluevofvthevtherapeuticv
indexvisvsmall,vtoxicityvisvmorevlikely.
DIF: Recall
REF:v DrugvNamesv(DrugvSubstitution)v|vp.v5vOBJ:v 4
TOP:v NBDHE,v6.0.vPharmacology
v v v v v v v
tal Hygienist 9th Edition
v v v
by Elena Bablenis Haveles, Chapters 1 - 26 A+
v v v v v v v v
,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and PrescriptionWriting
v v v v v v v v v v
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
v v v v v v v v
MULTIPLEvCHOICE
1. Knowledgevofvpharmacologyvaidsvthevdentalvprofessionalvin
a. obtainingvavpatient’svhealthvhistory.
b. administeringvdrugsvinvthevoffice.
c. handlingvemergencyvsituations.
d. selectionvofvavnonprescriptionvmedication.
e. Allvofvthevabove.
ANSWER:vE
Allvofvthevchoicesvarevtrue.vBecausevmanyvofvourvpatientsvarevbeingvtreatedvwithvdrugs,vknowledgevofvph
armacologyvhelpsvinvunderstandingvandvinterpretingvpatients’vresponsesvtovhealthvhistoryvquestions.vKno
wledgevofvthevtherapeuticvandvadverseveffectsvofvmedicationsvobviouslyvhelpsvinvtheirvpropervadministra
tionvinvthevoffice.vEmergencyvsituationsvmayvbevcausedvbyvdrugsvorvtreatedvbyvdrugs;vthus,vknowledgevof
vpharmacologyvisvofvgreatvhelp,vespeciallyvbecausevavrapidvresponsevisvsometimesvrequired.vAvclearvund
erstandingvofvthevconceptsvofvdrugvaction,vdrugvhandlingvbyvthevbody,vandvdrugvinteractionsvwillvallowvt
hevdentalvpractitionervtovmakevpropervjudgmentsvandvgraspvthevconceptsvrelevantvtovnewvdrugvtherapiesv
onvthevmarket.
DIF: Application
REF:v RolevofvthevDentalvHygienistv(Medication/HealthvHistory),vRolevofvthevDentalvHygienistv(MedicationvA
dministration),vRolevofvthevDentalvHygienistv(EmergencyvSituations),vRolevofvthevDentalvHygienistv(Nonpre
scriptionvMedication)v|vpp.v2-3 OBJ: 1
TOP:v NBDHE,v6.0.vPharmacology
2. Whichvofvthevfollowingvstatementsvisvtruevregardingvplanningvappointments?
a. Whethervorvnotvpatientsvarevtakingvmedicationvforvsystemicvdiseasesvisvofvlittle
consequencevinvthevdentalvoffice.
b. Asthmaticvpatientsvshouldvhavevdentalvappointmentsvinvthevmorning.
c. Diabeticvpatientsvusuallyvhavevfewervproblemsvwithvavmorningvappointment
comparedvwithvafternoonvappointments.
d. BothvBvandvCvarevtrue.
ANSWER:vD
Asthmaticvpatientsvwhovexperiencevdentalvanxietyvshouldvschedulevtheirvappointmentsvwhenvtheyvarevnot
vrushedvorvundervpressurevearlyvinvthevmorning.vDiabeticvpatientsvusuallyvhavevrelativelyvfewervproblem
svwithvavmorningvappointment.vPatientsvtakingvmedicationvforvsystemicvdiseasesvmayvrequirevspecialvhan
dlingvinvthevdentalvoffice.
, DIF: Comprehension
REF:v RolevofvthevDentalvHygienistv(AppointmentvScheduling)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
3. Nutritionalvorvherbalvsupplements
a. carryvthevU.S.vFoodvandvDrugvAdministrationv(FDA)vapprovalvforvdiseasevstates.
b. arevnotvdrugs.
c. canvcausevadverseveffects.
d. willvnotvinteractvwithvothervdrugsvthevpatientvmayvbevtaking.
ANSWER:vC
Nutritionalvorvherbalvsupplementsvarevquitevcapablevofvcausingvadverseveffects.vThevmajorityvofvn
utritionalvorvherbalvsupplementsvdovnotvcarryvFDAvapprovalvforvtreatingvdiseasevstates.vThesevsu
pplementsvarevdrugsvandvcanvcausevadverseveffectsvandvinteractvwithvdifferentvdrugs.
DIF:v Comprehension
REF:vRolevofvthevDentalvHygienistv(NutritionalvorvHerbalvSupplements)v|vp.v3v
OBJ:v 1 TOP:v NBDHE,v6.0.vPharmacology
4. Whichvtypevofvdrugvnamevusuallyvbeginsvwithvavlowercasevletter?
a. Brandvname
b. Codevname
c. Genericvname
d. Tradevname
ANSWER:vC
Beforevanyvdrugvisvmarketed,vitvisvgivenvavgenericvnamevthatvbecomesvthev“official”vnamevofvthevdrug.vEa
chvdrugvisvassignedvonlyvonevgenericvnamevselectedvbyvthevU.S.vAdoptedvNamevCouncil,vandvthevnamevi
svnotvcapitalized.vThevbrandvnamevisvequivalentvtovthevtradevnamevandvisvcapitalized.vAlthoughvthevbrandv
namevisvtechnicallyvthevnamevofvthevcompanyvmarketingvthevproduct,vthisvtermvisvoftenvusedvinterchangea
blyvwithvthevtradevname.vThevcodevnamevisvthevinitialvtermvusedvwithinvavpharmaceuticalvcompanyvtovrefe
rvtovavdrugvwhilevitvisvundergoingvinvestigationvandvisvoftenvavcombinationvofvcapitalvlettersvandvnumber
s,vthevlettersvrepresentingvanvabbreviationvofvthevcompanyvname.
DIF: Comprehension
REF:vDrugvNamesv|vp.v4vOBJ:v 3
TOP:v NBDHE,v6.0.vPharmacology
5. Avdrug’svgenericvnamevisvselectedvbyvthe
a. pharmaceuticalvcompanyvmanufacturingvit.
b. FoodvandvDrugvAdministrationv(FDA).
c. U.S.vAdoptedvNamevCouncil.
d. FederalvPatentvOffice.
, ANSWER:vC
Eachvdrugvisvassignedvonlyvonevgenericvnamev(e.g.,vibuprofen).vItvisvselectedvbyvthevU.S.vAdoptedvName
vCouncil.vThevgenericvnamevisvnotvselectedvbyvthevFDAvorvthevFederal vPatentvOffice.vThevpharmaceutic
alvcompanyvmanufacturingvthevdrugvclearlyvhasvanvinfluencevonvthevgenericvnamevgivenvitsvdrug,vbutvthevf
inalvdecisionvisvnotvthevcompany’s.
DIF: Recall REF:v DrugvNamesv|vp.v4
OBJ:v 3vTOP:v NBDHE,v6.0.vPharmacology
6. Whichvofvthevfollowingvisvtruevconcerningvgenericvandvtradevnamesvofvdrugs?
a. Avdrugvmayvonlyvhavevonevgenericvnamevandvonevtradevname.
b. Avdrugvmayvonlyvhavevonevgenericvname,vbutvitvmayvhavevseveralvtradevnames.
c. Avdrugvmayvhavevseveralvgenericvnames,vbutvitvmayvonlyvhavevonevtradevname.
d. Avdrugvmayvhavevseveralvgenericvnamesvandvseveralvtradevnames.
ANSWER:vB
Eachvdrugvhasvonlyvonevgenericvnamevbutvmayvhavevseveralvtradevnames.vForveachvdrug,vtherevisvonlyvon
evgenericvname.vItvisvnotvcapitalized,vandvitvbecomesvthev“official”vnamevofvthevdrug.vThevpharmaceutical
vcompanyvdiscoveringvthevdrugvgivesvthevdrugvavtradevname.vThevtradevnamevisvprotectedvbyvthevFederalv
PatentvLawvforv20vyearsvfromvthevearliestvclaimedvfilingvdate,vplusvpatentvtermvextensions.vAlthoughvthevb
randvnamevisvtechnicallyvthevnamevofvthevcompanyvmarketingvthevproduct,vitvisvoftenvusedvinterchangeabl
yvwithvthevtradevname.
DIF: Comprehension
REF:vDrugvNamesv|vp.v4vOBJ:v 3
TOP:v NBDHE,v6.0.vPharmacology
7. Twovdrugsvthatvarevfoundvtovbevchemicallyvequivalent,vbutvnotvbiologicallyvequivalentvorvt
herapeuticallyvequivalentvarevsaidvtovdiffervin
a. potency.
b. efficacy.
c. bioavailability.
d. therapeuticvindex.
ANSWER:vC
Avpreparationvcanvbevchemicallyvequivalentvyetvnotvbiologicallyvorvtherapeuticallyvequivalent.vThesevpr
oductsvarevsaidvtovdiffervinvtheirvbioavailability.vThevpotencyvofvavdrugvisvavfunctionvofvthevamountvofvdrug
vrequiredvtovproducevanveffect. vThevefficacyvisvthevmaximumvintensityvofveffectvorvresponsevthatvcanvbev
producedvbyvavdrug.vThevtherapeuticvindexvisvthevratiovofvthevlethalvdosevforv50%vofvthevexperimentalvan
imalsvdividedvbyvtheveffectivevdosevforv50%vofvthevexperimentalvanimals.vIfvthevvaluevofvthevtherapeuticv
indexvisvsmall,vtoxicityvisvmorevlikely.
DIF: Recall
REF:v DrugvNamesv(DrugvSubstitution)v|vp.v5vOBJ:v 4
TOP:v NBDHE,v6.0.vPharmacology
